AAT

April 21, 2017April 21, 2017

Heartburn Therapy May Not Be Effective or Safe for IPF Patients on Esbriet

Heartburn treatments, such as antacid therapy (AAT), may not be effective or safe as an add-on treatment for idiopathic pulmonary fibrosis (IPF) patients receiving Esbriet (pirfenidone), according to a study. ... Read more

September 28, 2015September 28, 2015

Inhibrx, The Alpha-1 Project Partner to Advance Recombinant AAT for Emphysema

Emphysema, News

Inhibrx, a biologic therapeutic company focused on the treatment of high unmet medical needs in oncology, infectious disease and inflammatory conditions, and The Alpha-1 Project, Inc. (TAP), a wholly owned subsidiary of the Alpha-1 ... Read more

May 20, 2014May 20, 2014

Kamada Reports Preliminary Results from Phase II/III Pivotal Trial in Europe and Canada of Inhaled AAT to Treat Alpha-1 Antitrypsin Deficiency

Emphysema, News

Ness Ziona, Israel, based plasma-derived protein therapeutics company Kamada Ltd. this week announced preliminary top-line results from its recently completed Phase II/III pivotal clinical trial in Europe and Canada of ... Read more